HIV post exposure prophylaxis induced bicytopenia: a case report

Long and short term side effects of antiretroviral drugs are not fully understood yet. Here a case of reversible blood count changes following post exposure prophylaxis with tenofovir/emtricitabin and lopinavir/ritonavir is reported. We propose that antiretroviral drugs used in post exposure prophyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Schleenvoigt, Benjamin T, Fobiwe, John P, Keller, Peter M, Hagel, Stefan, Pletz, Mathias W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922541/
https://www.ncbi.nlm.nih.gov/pubmed/24506969
http://dx.doi.org/10.1186/1742-6405-11-11
_version_ 1782303464979693568
author Schleenvoigt, Benjamin T
Fobiwe, John P
Keller, Peter M
Hagel, Stefan
Pletz, Mathias W
author_facet Schleenvoigt, Benjamin T
Fobiwe, John P
Keller, Peter M
Hagel, Stefan
Pletz, Mathias W
author_sort Schleenvoigt, Benjamin T
collection PubMed
description Long and short term side effects of antiretroviral drugs are not fully understood yet. Here a case of reversible blood count changes following post exposure prophylaxis with tenofovir/emtricitabin and lopinavir/ritonavir is reported. We propose that antiretroviral drugs used in post exposure prophylaxis may have a significant impact on hematopoiesis.
format Online
Article
Text
id pubmed-3922541
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39225412014-02-13 HIV post exposure prophylaxis induced bicytopenia: a case report Schleenvoigt, Benjamin T Fobiwe, John P Keller, Peter M Hagel, Stefan Pletz, Mathias W AIDS Res Ther Case Report Long and short term side effects of antiretroviral drugs are not fully understood yet. Here a case of reversible blood count changes following post exposure prophylaxis with tenofovir/emtricitabin and lopinavir/ritonavir is reported. We propose that antiretroviral drugs used in post exposure prophylaxis may have a significant impact on hematopoiesis. BioMed Central 2014-02-07 /pmc/articles/PMC3922541/ /pubmed/24506969 http://dx.doi.org/10.1186/1742-6405-11-11 Text en Copyright © 2014 Schleenvoigt et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Schleenvoigt, Benjamin T
Fobiwe, John P
Keller, Peter M
Hagel, Stefan
Pletz, Mathias W
HIV post exposure prophylaxis induced bicytopenia: a case report
title HIV post exposure prophylaxis induced bicytopenia: a case report
title_full HIV post exposure prophylaxis induced bicytopenia: a case report
title_fullStr HIV post exposure prophylaxis induced bicytopenia: a case report
title_full_unstemmed HIV post exposure prophylaxis induced bicytopenia: a case report
title_short HIV post exposure prophylaxis induced bicytopenia: a case report
title_sort hiv post exposure prophylaxis induced bicytopenia: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922541/
https://www.ncbi.nlm.nih.gov/pubmed/24506969
http://dx.doi.org/10.1186/1742-6405-11-11
work_keys_str_mv AT schleenvoigtbenjamint hivpostexposureprophylaxisinducedbicytopeniaacasereport
AT fobiwejohnp hivpostexposureprophylaxisinducedbicytopeniaacasereport
AT kellerpeterm hivpostexposureprophylaxisinducedbicytopeniaacasereport
AT hagelstefan hivpostexposureprophylaxisinducedbicytopeniaacasereport
AT pletzmathiasw hivpostexposureprophylaxisinducedbicytopeniaacasereport

Ejemplares similares